New ovarian cancer drug 'very promising'
Media playback is unsupported on your device

Ovarian cancer drug 'very promising'

Researchers from the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust tried the new drug, ONX-0801, on women who did not respond to other drugs.

Marianne, who took part in the trial, tells the BBC it was her "only option".

  • 03 Jun 2017
Go to next video: Dogs’ noses help scientists sniff out cancer